Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 6
2003 7
2004 7
2005 5
2006 7
2007 2
2008 8
2009 6
2010 5
2011 4
2012 4
2013 2
2014 3
2016 2
2017 3
2018 2
2019 2
2020 4
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Rajkumar SV, Harousseau JL, Durie B, Anderson KC, Dimopoulos M, Kyle R, Blade J, Richardson P, Orlowski R, Siegel D, Jagannath S, Facon T, Avet-Loiseau H, Lonial S, Palumbo A, Zonder J, Ludwig H, Vesole D, Sezer O, Munshi NC, San Miguel J; International Myeloma Workshop Consensus Panel 1. Rajkumar SV, et al. Blood. 2011 May 5;117(18):4691-5. doi: 10.1182/blood-2010-10-299487. Epub 2011 Feb 3. Blood. 2011. PMID: 21292775 Free PMC article.
The proteasome.
Dalton WS. Dalton WS. Semin Oncol. 2004 Dec;31(6 Suppl 16):3-9; discussion 33. doi: 10.1053/j.seminoncol.2004.10.012. Semin Oncol. 2004. PMID: 15799238 Review.
Optimizing Cancer Treatment Using Game Theory: A Review.
Stanková K, Brown JS, Dalton WS, Gatenby RA. Stanková K, et al. Among authors: dalton ws. JAMA Oncol. 2019 Jan 1;5(1):96-103. doi: 10.1001/jamaoncol.2018.3395. JAMA Oncol. 2019. PMID: 30098166 Free PMC article. Review.
The tumor microenvironment: focus on myeloma.
Dalton WS. Dalton WS. Cancer Treat Rev. 2003 May;29 Suppl 1:11-9. doi: 10.1016/s0305-7372(03)00077-x. Cancer Treat Rev. 2003. PMID: 12738239 Review.
Proteomic contributions to personalized cancer care.
Koomen JM, Haura EB, Bepler G, Sutphen R, Remily-Wood ER, Benson K, Hussein M, Hazlehurst LA, Yeatman TJ, Hildreth LT, Sellers TA, Jacobsen PB, Fenstermacher DA, Dalton WS. Koomen JM, et al. Among authors: dalton ws. Mol Cell Proteomics. 2008 Oct;7(10):1780-94. doi: 10.1074/mcp.R800002-MCP200. Epub 2008 Jul 29. Mol Cell Proteomics. 2008. PMID: 18664563 Free PMC article. Review.
Implementing personalized medicine in a cancer center.
Fenstermacher DA, Wenham RM, Rollison DE, Dalton WS. Fenstermacher DA, et al. Among authors: dalton ws. Cancer J. 2011 Nov-Dec;17(6):528-36. doi: 10.1097/PPO.0b013e318238216e. Cancer J. 2011. PMID: 22157297 Free PMC article. Review.
Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas.
Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, Zhang Y, Chan JC, Fu K, Marquez VE, Chen-Kiang S, Moscinski LC, Seto E, Dalton WS, Wright KL, Sotomayor E, Bhalla K, Tao J. Zhang X, et al. Among authors: dalton ws. Cancer Cell. 2023 Jun 12;41(6):1198. doi: 10.1016/j.ccell.2023.05.003. Cancer Cell. 2023. PMID: 37311416 No abstract available.
81 results